3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
43
Lymphoma, Follicular
23
Lymphoma, Non-Hodgkin
17
Lymphoma, Mantle-Cell
16
Lymphoma, Large B-Cell, Diffuse
15
Lymphoma
14
Lymphoma, B-Cell, Marginal Zone
12
Lymphoma, B-Cell
8
Recurrence
7
Neoplasms
6
Burkitt Lymphoma
5
Neoplasm, Residual
3
Leukemia, B-Cell
3
Leukemia, Hairy Cell
2
Leukemia
2
Dendritic Cell Sarcoma, Interdigitating
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Part1: Advanced B-cell Malignancies
1
Ovarian Neoplasms
1
Mesothelioma
1
Melanoma
1
Mature B-cell Malignancies
1
Mature B-Cell Malignancies
1
Lymphoproliferative Disorders
1
Lymphatic Diseases
1
Leukemia, Prolymphocytic
1
Interventions
pembrolizumab
44
Gemcitabine
23
enfortumab vedotin
21
Nivolumab
20
Cisplatin
17
avelumab
16
Magnetic Resonance Spectroscopy
15
Carboplatin
14
atezolizumab
13
Specimen Handling
12
Docetaxel
11
sacituzumab govitecan
9
Paclitaxel
8
Ipilimumab
8
durvalumab
6
Mitomycin
5
Fluorodeoxyglucose F18
5
cabozantinib
4
Taxes
4
toripalimab
3
pemigatinib
3
erdafitinib
3
X-Rays
3
Radiosurgery
3
Platinum
3
Pemetrexed
3
Immunoglobulin G
3
CTLA-4 Antigen
3
Biopsy
3
ALT-803
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
obinutuzumab
×
1 year
×
Clear all
No trials found.